# ETRA (Electra Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Electra Therapeutics, Inc. reported $410.8M in total assets through September 30, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ETRA
- Markdown: https://convexityos.com/fundamentals/ETRA.md
- SEC CIK: 0002088082
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:45 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002088082&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Sep 30, 2026 |
| Operating Income | FY 2026 | -- | Operating profit |
| Net Income | FY 2026 | -- | GAAP bottom line |
| Diluted EPS | FY 2026 | -- | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $402.5M | Total debt: $1.71M |

## Income Statement

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $17.27M | -- | -- | $14.90M | -- | -- |
| Total Operating Expenses | $25.06M | -- | -- | $17.02M | -- | -- |
| **Operating Income** | -$25.06M | -- | -- | -$17.02M | -- | -- |
| Interest Income | $1.13M | -- | -- | $232K | -- | -- |
| Interest Expense | $0 | -- | -- | $1.30M | -- | -- |
| **Net Income** | -$23.93M | -$26.75M | -$22.17M | -$18.09M | -$17.57M | -$7.79M |
| Basic EPS | -$3.47 | -- | -- | -$616.86 | -- | -- |
| **Diluted EPS** | -$3.47 | -- | -- | -$616.86 | -- | -- |
| Basic Shares Outstanding | 6.9M | -- | -- | 29.3K | -- | -- |
| Diluted Shares Outstanding | 6.9M | -- | -- | 29.3K | -- | -- |

## Balance Sheet

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Dec 2025 |
| --- | --- | --- |
| Cash & Cash Equivalents | $256.4M | $33.01M |
| Short-Term Investments | $146.1M | $53.51M |
| **Cash & Short-Term Investments** | $402.5M | $86.52M |
| **Total Current Assets** | $406.9M | $95.49M |
| Property, Plant & Equipment, Net | $518K | $674K |
| Other Non-Current Assets | $1.80M | $1.10M |
| **Total Non-Current Assets** | $3.89M | $3.88M |
| **Total Assets** | $410.8M | $99.37M |
| Accounts Payable | $8.06M | $4.08M |
| **Total Current Liabilities** | $16.98M | $9.73M |
| Long-Term Debt | $0 | -- |
| **Total Non-Current Liabilities** | $939K | $1.48M |
| **Total Liabilities** | $17.92M | $11.21M |
| **Total Debt (incl. Leases)** | $1.71M | $2.09M |
| Common Stock | $6.0K | $0 |
| Retained Earnings | -$245.8M | -$173.0M |
| Accumulated Other Comp. Income | $13K | $21K |
| **Total Stockholders' Equity** | $392.9M | -$163.4M |
| Total Equity | $392.9M | -$163.4M |

## Cash Flow Statement

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$23.93M | -$26.75M | -$22.17M | -$18.09M | -$17.57M | -$7.79M |
| Stock-Based Compensation | $4.59M | -- | -- | $302K | -- | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Current Ratio | 23.97x | -- | -- | -- | -- | -- |
| Quick Ratio | 23.71x | -- | -- | -- | -- | -- |
| Debt to Equity | 0.00x | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
